老年评估在肺癌患者中应用的研究进展

Research progress on the application of geriatric assessment in patients with lung cancer

肺癌是老年人群最常见的恶性肿瘤,由于缺乏足够的老年组患者临床试验数据,针对该人群的抗肿瘤方案制定存在一定困难。目前常用的临床评估方法无法准确预测老年患者在抗肿瘤治疗过程中对药物的耐受性情况及生存情况。老年评估及其相关简易量表作为抗肿瘤治疗前的简短评估,可帮助临床医生更好地了解患者的健康状况和个体生存率,并指导临床医生制定合理的治疗方案及干预措施。

Lung cancer is the most common malignant tumor in the elderly population.Due to the lack of sufficient clinical trial data for elderly patients,it is difficult to develop anti-tumor programs for this population.Currently,the most commonly used clinical evaluation methods cannot accurately predict the drug tolerance and survival of elderly patients during the course of antitumor therapy.Geriatric assessment and its related simple scale,as a brief assessment before anti-tumor treatment,can help celinicians better understand the health status of patients and individual survival rate,and can guide clinicians to formulate reasonable treatment plans and interventions.